Health advocate says FDA must walk a 'fine line' to ensure affordable drugs are safe

The Hill

29 May 2019 - Public health advocate Dinesh Thakur said in an interview that aired Wednesday that the FDA is walking a fine line between making medicines affordable while ensuring they are of high quality.

"The FDA walks a very fine line between trying to get affordable medicines to everybody who needs them, while also ensuring the quality," Thakur told Hill.TV's Krystal Ball and Saagar Enjeti on "Rising."

Thakur discussed cases where the FDA has had to crack down on drug companies even amid worries about the supply of medicines.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Safety